Pfizer Inc
NYSE: PFE
$26.91
+$0.29 (+1.1%)
Closing Price on January 30, 2025
PFE Articles
Monday's top analyst upgrades, downgrades and initiations include AbbVie, Alcoa, Apple, Deckers Outdoor, Dish Network, Pfizer and Petrobras.
Published:
thinkstockFebruary 5, 2015: Markets opened higher on Thursday on news that the Bank of Greece would continue to be able to access funds from the European Central Bank, at least for a while. New...
Published:
Last Updated:
If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today.
Published:
Amidst the excitement about Facebook's nearly 50% revenue growth rate and its successful, accelerating movement into mobile, something is lost.
Published:
Pfizer reported better-than-expected fourth-quarter earnings Tuesday before the U.S. markets opened.
Published:
Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year to date, Its shares are up 11%.
Published:
Last Updated:
thinkstockJanuary 13, 2015: Markets opened higher again on Tuesday but stocks drifted lower all day and finally broke through into the read by mid-afternoon. Oil had another up and down day, closing...
Published:
Last Updated:
One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night and day different from the Pfizer of 2005.
Published:
One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have upside performance above what was expected.
Published:
thinkstockDecember 26, 2014: Markets opened higher on Friday on a morning when it was difficult to find any market-moving news at all. Energy opened higher but traded about $1 a barrel lower (down...
Published:
Last Updated:
With investors loving dividends so much, 24/7 always tries to take a look at what the Dogs of the Dow will look like for the year ahead.
Published:
While this was generally a known event coming down the pipe, arthritis drug Celebrex now has a generic competitor in America.
Published:
thinkstockDecember 4, 2014: Markets opened higher on Friday after the federal government released a better-than-expected report on employment. Job gains rose to their highest level since 2012, and...
Published:
Last Updated:
The U.S. equity market is still a great place to be, and the analysts at Jefferies may have a good plan for where to rotate some 2014 winners and losers.
Published:
A new report from Jefferies focuses on four stocks to buy that have impending events that could make a difference for investors.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.